Search

everythinglearnresearchcommunity

for

Search:↓

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Cetuximab can cause excessive eyelash growth.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Targeting colon cancer stem cells might lead to better treatment results.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

Tacalcitol cream effectively and safely treated a rare skin condition called Lichen Spinulosus in two cases.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Strontium ranelate is no longer available for treatment.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Taking vitamin C and vitamin E twice a day can help prevent sunburn and DNA damage from UVB exposure.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Lack of functional CYLD in mice leads to early aging and cancer.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.